Target intelligence / Profile preview

ANKRD35 divergent transcript (ANKRD35-DT)

Target
ANKRD35-DT
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

ANKRD35 divergent transcript (ANKRD35-DT) is annotated as a long non-coding RNA gene. lncRNAs such as ANKRD35-DT are DNA regions transcribed into RNA but not translated into proteins. "Divergent transcript" refers to the phenomenon where transcription occurs in opposite directions from a promoter, generating both a protein-coding transcript (e.g., ANKRD35 proper) and a non-coding transcript (ANKRD35-DT)[1]. Most divergent transcripts are unstable and of unknown functional relevance, but some lncRNAs regulate gene expression or chromatin structure[1][5]. There is no evidence that ANKRD35-DT is a protein-coding gene, nor that it functions as a classical pharmacological target (receptor, enzyme, etc.). Its specific molecular function, disease involvement, and pharmaceutical relevance have not been established[5].

Other names
ANKRD35 Divergent TranscriptANKRD35-DT
02

Mechanism of action

None reported

03

Biological functions

Other (no confirmed molecular function; as a divergent transcript, it may be associated with transcriptional regulation or genome architecture as seen for many lncRNAs, but its specific activity is unknown)
04

Disease associations

Other (no established role in specific diseases)

Beyond the preview

Go deeper on ANKRD35 divergent transcript (ANKRD35-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD35 divergent transcript (ANKRD35-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call